You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
南京醫藥(600713.SH):合肥大藥房擬收購福潤堂持有的門店資產組
格隆匯 08-17 21:17

格隆匯8月17日丨南京醫藥(600713.SH)公佈,公司全資子公司南京醫藥國藥有限公司(以下簡稱“南京醫藥國藥”)之全資子公司南京醫藥合肥大藥房連鎖有限公司(以下簡稱“合肥大藥房”)擬以不超過3960萬元(人民幣,下同)的價格收購安徽福潤堂大藥房連鎖有限公司(以下簡稱“福潤堂”)持有的43家藥品零售門店資產組(包括固定資產、長期待攤費用、客户資源、營銷渠道、相關資質等)。

“福潤堂”現有43家門店主要為社區店,均具備合肥市定點醫保資格,主要面向社區居民銷售中西成藥品、中藥飲片、保健品、醫療器械等大類商品。其門店位於4個市轄區、2個經濟開發區、2個市轄縣,門店主要來自於收購單體藥房和近兩年自行新開的藥房,目前都處於正常經營狀態。

經初步測算,合肥大藥房完成收購後,福潤堂43家門店每年營業收入遞增10%,到第5年營收規模約8000萬元,利潤約640萬元;五年累計經營性利潤近2000萬元。本次交易預計不會對公司2020年主營業務產生重大影響。

合肥大藥房收購43家門店資產組後,在充分發揮協同效應,有效輸出成熟門店運營管控模式,與現有存量門店深度融合,全面提升盈利能力上存在不確定性。

針對上述風險,合肥大藥房在收購完成後,着力協調內部資源,基於自身在合肥市場品牌影響力及雙方資源進行優勢互補(諸如門店位置互補、會員互補、品種互補等),整合重點品類品規,擴大客户羣尤其是會員羣體銷售,引入“互聯網+藥店”的O2O等新業務模式,促進規模及品牌效應逐步顯現,最終達到收購後門店銷售和盈利能力預期目標。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account